Sangamo Therapeutics Inc (NASDAQ:SGMO)

24.95
Delayed Data
As of Feb 23
 -0.45 / -1.77%
Today’s Change
3.65
Today|||52-Week Range
27.50
+52.13%
Year-to-Date
Recession is Coming! Not
Feb 23 / Zacks.com - Paid Partner Content
Sound Familiar? Dovish Fed Talk Induces Stock Reversal
Feb 22 / TheStreet.com - Paid Partner Content
Sangamo Therapeutics (SGMO) Looks Good: Stock Adds 14.4% in Session
Feb 23 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close25.40
Today’s open25.65
Day’s range24.66 - 26.85
Volume3,830,383
Average volume (3 months)1,682,650
Market cap$2.1B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+31.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+88.60%
P/E ratioNM
Price/Sales35.02
Price/Book--

Competitors

----
EPZMEpizyme Inc+0.50+2.92%
FPRXFive Prime Therapeut...+0.51+2.88%
MNTAMomenta Pharmaceutic...+0.40+2.37%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$36.6M
Annual profit (last year)-$54.6M
Net profit margin-149.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts